Showing results (171-180 of 188) with videos related to

Sort By:
Pageof 19
Theranostics|June 16, 2025
Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapyFelix L Herr, Christian Dascalescu, Ricarda Ebner, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2020
International Histopathology Consensus for Unilateral Primary AldosteronismTracy Ann Williams, Celso E Gomez-Sanchez, William E Rainey, et al.
Cancer Research|July 22, 2024
Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and MetastasisCamino Bermejo-Rodriguez, Joaquín Araos Henríquez, Giuseppina Caligiuri, et al.
Hypertension (Dallas, Tex. : 1979)|July 18, 2018
Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary AldosteronismLucie S Meyer, Xiao Wang, Eva Sušnik, et al.
Gastroenterology|October 15, 2013
MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progressionAdam E Frampton, Leandro Castellano, Teresa Colombo, et al.
Targeted Oncology|June 30, 2025
Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunich<sup>LMU</sup> Molecular Tumor BoardKlara Dorman, Christoph J Auernhammer, Christine Spitzweg, et al.
International Journal of Cancer|September 30, 2018
Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcomaMartin F Orth, Julia S Gerke, Thomas Knösel, et al.
Endocrinology|July 20, 2019
Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor CulturesMaria Fankhauser, Nicole Bechmann, Michael Lauseker, et al.
Gut|September 15, 2022
GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinomaMónica P de Andrés, Richard J Jackson, Irene Felipe, et al.
European Journal of Endocrinology|May 13, 2021
Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paragangliomaMasanori Murakami, Na Sun, Christian Greunke, et al.
Pageof 19